Comment on

• Vasopressin, steroids, and epinephrine and neurologically favorable survival after in-hospital cardiac arrest: a randomized clinical trial.

  Mentzelopoulos SD, Malachias S, Chamos C, Konstantopoulos D, Ntaidou T, Papastylianou A, Kolliantzaki I, Theodoridi M, Ischaki H, Makris D, Zakynthinos E, Zintzaras E, Sourlas S, Aloizos S, Zakynthinos SG. Mentzelopoulos SD, et al. JAMA. 2013 Jul 17;310(3):270-9. doi: 10.1001/jama.2013.7832. JAMA. 2013. PMID: 23860985 Clinical Trial.
• Results of the two incidence screenings in the National Lung Screening Trial.

  Aberle DR, DeMello S, Berg CD, Black WC, Brewer B, Church TR, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, Gatsonis CA, Gierada DS, Jain A, Jones GC, Mahon I, Marcus PM, Rathmell JM, Sicks J; National Lung Screening Trial Research Team. Aberle DR, et al. N Engl J Med. 2013 Sep 5;369(10):920-31. doi: 10.1056/NEJMoa1208962. N Engl J Med. 2013. PMID: 24004119 Free PMC article. Clinical Trial.
• Target temperature management of 33°C and 36°C in patients with out-of-hospital cardiac arrest with initial non-shockable rhythm - a TTM sub-study.

  Frydland M, Kjaergaard J, Erlinge D, Wanscher M, Nielsen N, Pellis T, Åneman A, Friberg H, Hovdenes J, Horn J, Wetterslev J, Winther-Jensen M, Wise MP, Kuiper M, Stammet P, Cronberg T, Gasche Y, Hassager C. Frydland M, et al. Resuscitation. 2015 Apr;89:142-8. doi: 10.1016/j.resuscitation.2014.12.033. Epub 2015 Jan 25. Resuscitation. 2015. PMID: 25629544 Clinical Trial.